Myriad Genetics Inc
MYGN- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000899923
No open-market purchases or sales by Myriad Genetics Inc insiders were filed in the last 90 days; 196 institutions reported holding it in 13F filings for Q2 2026, worth $507.8M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Myriad Genetics Inc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 186
- −8 vs. Q4 2023
- Shares held
- 93.8M
- +3.94M (+4.4%) vs. Q4 2023
- Total value
- $2.00B
- +$280.4M (+16.3%) vs. Q4 2023
- New holders
- 21
- 73 more added
- Sold out
- 29
- 62 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MYGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 196 | $507.8M |
| Q1 2026 | 204 | $519.2M |
| Q4 2025 | 221 | $567.1M |
| Q3 2025 | 221 | $639.8M |
| Q2 2025 | 221 | $480.5M |
| Q1 2025 | 228 | $832.9M |
| Q4 2024 | 221 | $1.27B |
| Q3 2024 | 246 | $2.48B |
| Q2 2024 | 223 | $2.25B |
| Q1 2024 | 186 | $2.00B |
| Q4 2023 | 194 | $1.72B |
| Q3 2023 | 186 | $1.33B |
| Q2 2023 | 188 | $1.88B |
| Q1 2023 | 190 | $1.91B |
| Q4 2022 | 196 | $1.17B |
| Q3 2022 | 191 | $1.55B |
| Q2 2022 | 199 | $1.46B |
| Q1 2022 | 205 | $1.99B |
| Q4 2021 | 197 | $2.16B |
| Q3 2021 | 213 | $2.56B |
| Q2 2021 | 201 | $2.31B |
| Q1 2021 | 197 | $2.25B |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Myriad Genetics Inc; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Clarus Wealth Advisors | 0 | $0 | 0.00% | −10,119−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −2,819−100.0% | Sold out |
| First Horizon Advisors, Inc. | 0 | $0 | 0.00% | −1,175−100.0% | Sold out |
| Principal Securities, Inc. | 0 | $0 | 0.00% | −476−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −412−100.0% | Sold out |
| DAGCO, Inc. | 0 | $0 | 0.00% | −276−100.0% | Sold out |
| Bokf, NA | 0 | $0 | 0.00% | −159−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −135−100.0% | Sold out |
| Arlington Trust Co LLC | 0 | $0 | 0.00% | −145−100.0% | Sold out |
| Jones Financial Companies LLLP | 0 | $0 | 0.00% | −106−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −61−100.0% | Sold out |
| AdvisorNet Financial, Inc | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Tucker Asset Management LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| JNBA Financial Advisors | 0 | $0 | 0.00% | −10−100.0% | Sold out |